{"schema_version":"secwatch.filing_event.v1","accession":"0000711404-22-000038","form_type":"8-K","ticker":"COO","cik":"0000711404","company_name":"COOPER COMPANIES, INC.","filed_at":"2022-08-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.965453+00:00","generated_at":"2026-06-23T18:58:48.724912+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cooper Q3 revenue $843.4M (+10% YoY); non-GAAP EPS $3.19 down 6%; FY22 guide $3.29-3.31B","bullets":["Revenue $843.4M (+10% YoY); CooperVision +2% to $566.3M, CooperSurgical +35% to $277.1M.","GAAP diluted EPS $1.98 (down $10.39); non-GAAP diluted EPS $3.19 (down 6% vs $3.41).","Non-GAAP gross margin 66% (down 200bps); non-GAAP operating margin 23% (down 400bps).","Free cash flow $217.3M; net debt $2.6B (down $218M QoQ); adjusted leverage 2.44x.","FY2022 guidance: revenue $3.29-3.31B, non-GAAP EPS $12.72-$12.87; Q4 rev $830-850M."],"urls":{"canonical":"https://secwatch.observer/filing/0000711404-22-000038","json":"https://secwatch.observer/filing/0000711404-22-000038.json","markdown":"https://secwatch.observer/filing/0000711404-22-000038.md","text":"https://secwatch.observer/filing/0000711404-22-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711404/000071140422000038/0000711404-22-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711404/000071140422000038/coo-20220831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T18:58:48.724912+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}